These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 703706)
1. [Use of new mucolytic agent in bronchopulmonary pathology in children]. Spacagna G Minerva Pediatr; 1978 Aug; 30(15):1271-6. PubMed ID: 703706 [No Abstract] [Full Text] [Related]
2. [Indications for mucolytic therapy in emergency surgery]. Chirletti P; Cozza A; De Francesco F; Prezioso P; Tatta C Minerva Chir; 1979 Oct; 34(19):1305-8. PubMed ID: 503337 [No Abstract] [Full Text] [Related]
3. [Advantages of mucolytic treatment in bronchitis and bronchial asthma in children]. Hadydoń B; Chalon Z; Gruszecki J Pediatr Pol; 1966 Oct; 41(10):1177-80. PubMed ID: 5977179 [No Abstract] [Full Text] [Related]
4. [The significance of 2-thiol-propionamido-acetic acid in the treatment of cystic fibrosis]. Gargani GF; Vitiello B; Minicucci L; Micalizzi C; Richeri E; Romano C Minerva Pediatr; 1980 Nov; 32(22):1319-22. PubMed ID: 7219372 [No Abstract] [Full Text] [Related]
5. [A derivative of benzyl-amine in the therapy of respiratory diseases in children]. Gambi R; Ongaro F; Paoli R; Russo U Minerva Med; 1969 Sep; 60(76):3575-9. PubMed ID: 5823753 [No Abstract] [Full Text] [Related]
6. [Protective activity of tiopronin in relation to the acute exacerbation of chronic bronchitis]. Straneo G; Avanzini F; Scaglione F; Coppi G; Fraschini F Clin Ter; 1987 Mar; 120(6):503-10. PubMed ID: 2954743 [No Abstract] [Full Text] [Related]
7. [Clinical study of ucb 3983 in pediatric (author's transl)]. Goffart P Acta Paediatr Belg; 1973; 27(4):257-62. PubMed ID: 4358847 [No Abstract] [Full Text] [Related]
8. [Clinical experience with a new preparation with bronchosecretolytic action: Bisolvon or N-cyclohexyl-N-methyl-(2-amino-3,5-dibromobenzyl)-ammonium chloride]. Ercillo L; Mollica G Minerva Med; 1969 Sep; 60(76):3604-6. PubMed ID: 5823758 [No Abstract] [Full Text] [Related]
9. [The use of guacetisal in bronchopulmonary pathology in children]. Baggio S; Buonomo A Minerva Pediatr; 1983 Feb; 35(3):129-33. PubMed ID: 6843529 [No Abstract] [Full Text] [Related]
10. [The treatment of bronchial inflammatory diseases with a new drug association with mucolytic and expectorant activity]. Moncalvo F; Rossi A Clin Ter; 1971 Jul; 57(6):505-26. PubMed ID: 5136487 [No Abstract] [Full Text] [Related]
11. [The use of a new balsamic expectorant in bronchopulmonary pathology in children]. Daroda C; Galluzzo C; Porzia R; Riva E; Giovannini M Minerva Med; 1981 Feb; 72(7):363-6. PubMed ID: 7017486 [TBL] [Abstract][Full Text] [Related]
12. [Treatment of bronchial asthma and bronchitis with mucolytic drugs]. Chalon Z; Gruszecki J; Hadydoń B Pol Tyg Lek; 1966 Jul; 21(27):1040-2. PubMed ID: 5925941 [No Abstract] [Full Text] [Related]
13. [Mucolytic bisolven (further experiences in the treatment of chronic bronchitis and bronchial asthma)]. Beritić T Lijec Vjesn; 1970; 91(11):1200-2. PubMed ID: 5200810 [No Abstract] [Full Text] [Related]
14. [Spasmolytic and mucolytic agents in the treatment of acute dyspneic pneumopathies in children]. Manicatide ET; Căpraru H Pediatria (Bucur); 1973; 22(4):357-60. PubMed ID: 4761443 [No Abstract] [Full Text] [Related]
16. Clinical experience with a new secretolytic drug. Villa R; Orlandini GC Minerva Med; 1969 Sep; 60(76):3607-10. PubMed ID: 5823759 [No Abstract] [Full Text] [Related]
17. [Pediatric Asthma-Bisolvon suppositories in the treatment of asthmatic bronchitis and bronchial asthma in childhood]. Kessler H Fortschr Med; 1972 Sep; 90(27):993-5. PubMed ID: 4653175 [No Abstract] [Full Text] [Related]
18. [Clinico-experimental studies of the mucolytic action of N-cyclohexyl-N-methyl-(2-amino-3,5-dibromobenzyl)-ammonium chloride, in oral and parenteral administration, in acute and chronic pneumopathies]. Carnimeo N; Fino E; Maiorano V; Marzullo F Minerva Med; 1969 Sep; 60(76):3557-64. PubMed ID: 5823750 [No Abstract] [Full Text] [Related]
19. [Trial of a new synthetic fluidifying and analeptic agent: sobrerol. Its use in inflammatory bronchopneumopathies]. Marchioni CF; Monzali G Clin Ter; 1972 Jan; 60(2):135-42. PubMed ID: 4401338 [No Abstract] [Full Text] [Related]
20. [Clinical evaluation of the therapeutic efficacy of a new antiphlogistic and mucus-regulating drug, guaimesal, in acute and chronic bronchopneumopathies]. Bandera M; Fioretti M Clin Ter; 1984 Sep; 110(5):455-61. PubMed ID: 6238760 [No Abstract] [Full Text] [Related] [Next] [New Search]